Presented by:
ACPE # Pending
First-Time Offering; Initial Release Date Thursday, October 8, 2026
Successful completion of this activity counts as Live ACPE CE.
5:30 - 6:30 PM - Board Meeting
6:30 - 7:30 PM - CE Presentation
IN-PERSON RSVP Deadline:
We recommend that you create a WMed account before attending one of our meetings. Please see our Help Page for detailed instructions on creating a WMed account and claiming your CE credits.
Select the appropriate place in therapy for patients eligible for MABs for Alzheimer’s
Compare and contrast comorbidities, biomarkers, and patient specific factors that would support use of a MAB agent
Describe the mechanism of action of MABs for Alzheimer’s Disease
In support of improving patient care, this activity has been planned and implemented by Western Michigan University Homer Stryker M.D. School of Medicine and Western Michigan Society of Health-System Pharmacists. Western Michigan University Homer Stryker M.D. School of Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Credit amount subject to change.
Pharmacists & Pharmacy Technicians
Western Michigan University Homer Stryker M.D. School of Medicine designates this activity for 1.0 contact hours for pharmacists and pharmacy technicians. Pharmacists and pharmacy technicians should claim only credit commensurate with the extent of their participation in the activity.
For technical assistance, email webmaster@wmshp.net.
Click here to view our Privacy Policy.
